Companies: 10,795·Total market cap: $144.5T
Stevanato Group S.p.A.

Stevanato Group S.p.A.

STVNNYSEHealthcare● Active
$18.00
$-0.46(-2.49%)
Market Cap$4.9B
P/E Ratio
52W High$28
52W Low$12.89
Overview

Stevanato Group S.p.A. (STVN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · STVN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.51stvn eps ttm · stvn earnings per shareEarnings history
PE Ratio (TTM)35.3×stvn pe ratio ttm · stvn price to earningsPE Ratio deep dive
Revenue (TTM)$1.2Bstvn revenue ttm · stvn annual revenueFull revenue history
Dividend Yield0.35%does stvn pay dividends · stvn dividend yieldDividend history
Shares Outstanding273.0Mstvn shares outstanding · stvn floatShares outstanding history
Next EarningsAug 4, 2026Est.stvn earnings date · stvn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$1.14B▲ +3.21% YoY
202320242025
stevanato group s.p.a. revenue · stvn revenue 2025
FY 2025Net Income$134.3M▲ +14.01% YoY
202320242025
stevanato group s.p.a. net income · stvn profit 2025
FY 2025EPS$0.49▲ +13.95% YoY
202320242025
stvn eps · stevanato group s.p.a. earnings per share 2025
TTM:Revenue: $1.20BNet Income: $140.9MEPS: $0.51View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy8 analystsis stvn a buy · stvn analyst rating
Strong Buy
0
Buy
5
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$17.50Low
$18.00Current
$24.75Avg Target37.50% upside
$32.00High
stvn price target · stvn 12 month forecast

Total: 8 · Buy rate: 62.5%

The STVN analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $24.75, representing +37.50% upside from the current price of $18.00.

Stock Performance

Full History
1D-2.49%
1W-1.75%
1M-1.26%
3M+16.81%
YTD-10.54%
1Y-22.91%
5Y-8.49%

About Stevanato Group S.p.A.

CEOFranco Stevanato
IPO DateJul 16, 2021
Employees5,521
CountryIT

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products…

what is stevanato group s.p.a. · stvn stock overview · stevanato group s.p.a. company profile · who is stevanato group s.p.a. ceo · stvn NYSE · stevanato group s.p.a. headquarters · stevanato group s.p.a. business segments

About Stock Overview & Key Data

Stevanato Group S.p.A. (STVN) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since Jul 16, 2021. As of the latest trading session, STVN stock price is $18.00, with a market capitalization of $4.9B. The stock has returned -22.91% over the past 12 months and -10.54% year-to-date.

According to 8 Wall Street analysts, the consensus rating for Stevanato Group S.p.A. stock is Buy, with an average 12-month price target of $24.75. In fiscal year 2025, Stevanato Group S.p.A. reported revenue of $1.1B and net income of $134.3M. For detailed data — including Stevanato Group S.p.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Stevanato Group S.p.A. (STVN) stock price is $18.00. The stock is traded on NYSE under the ticker symbol STVN. The 52-week range is $12.89 – $28.00.

STVN stock priceSTVN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice